Sanjay Mehta
Analyst · Bank of America
Thank you, Mark. Good morning, everyone. Today I will cover the financial highlights of Q4 and review the financial details for 2019. Looking forward, I'll provide an update for midterm model, Q1 outlook and color around 2020 which will include our capital allocation plans. Now to Q4, revenues were $655 million, which were $25 million above the high end of our guidance range. Semi Test revenue of $439 million led the quarter over quarter growth driven by memory and SOC test demand enabling 5G infrastructure and higher speed flash and DRAM devices. System test group had revenue of $83 million, which grew quarter over quarter driven by our storage test solutions enabling system level test for SOCs. Industrial automation or IA revenue of $88 million had a seasonal increase in revenue over Q3 and grew year-over-year in an environment where significant auto industry headwinds exist. LitePoint revenue of $45 million grew quarter over quarter and year-over-year with new connectivity standard WiFi 6 and cellular 5G driving revenue. Non-GAAP gross margins were 58.5% a bit above our plan and slightly down quarter over quarter due to product mix. You'll see our non-GAAP operating expenses were up $19 million to $204 million from the third quarter due to a higher variable compensation, on higher profit, increased test spending to support design wins and an ongoing IA investment. Non-GAAP operating profit was 27% and non-GAAP EPS was $0.88. The tax rate, excluding discrete items for the quarter and the year was 15.5% on a GAAP basis, and 16.5% on a non-GAAP basis. We bought back 2.1 million shares for $131 million at an average price of $62.44 in the quarter. For the full year, we bought that 10.9 million shares at an average price of $45.89. Since the start of 2015, we have spent $1.97 billion to repurchase 60.8 million shares with an average price of $42.38, which delivered significant shareholder returns over the five year period. We ended the year with cash and marketable security balances of approximately $1 billion. Turning to the full year results of 2019. Teradyne revenues of $2.295 billion grew $194 million or 9%. $157 million of the growth is from our test portfolio and $37 million from IA. We had two customers with 10% or greater revenues in 2019 who will be disclosed in our 10-K filing. Gross margins were 58% and operating profit was 25%, which is consistent with 2018. EPS was $2.86, or 21% growth year-over-year. Breaking down the components of 2019 revenues. As Mark outlined, the SOC test revenues grew $67 million or 6% on strength in 5G sub-6 infrastructure, increased complexity in mobile devices, and millimeter wave development demand. In memory revenues were $266 million down 3% in the down market. Demand for higher speed NAND testers from existing customers and new entrants combined with DRAM wafer test demand highlighted the year. Late in the year we also received initial revenue for our Magnum Epic LPDDR5 DRAM package test system. In system test sales grew for third year in a row. Revenue of $287 million grew $71 million or 33% year-over-year, primarily on growth and storage test for both system level test and HDD test, which had sales of $115 million up from $67 million in 2018. We also saw annual growth in our defense and aerospace and production board test components of that STG. At LitePoint sales grew for a third year in a row as well. Revenue was $157 million, 19% above 2018 level. New connectivity standards were the biggest driver of demand. But we also saw surge in 5G cellular demand in Q4. IA revenue of $298 million grew 14% from 2018 on an as reported basis or 12% on a pro forma basis. Universal Robots revenue of $248 million or 6% year-over-year growth was below our original plan. As discussed by Mark, UR demand has 40% plus exposure to manufacturing in Europe and the automotive industry. Both of which face significant market headwinds in 2019. Recent Eurozone PMI data suggests a moderating trend, but no indication of improvement in the near-term. The auto outlook is similar. MiR revenues of $44 million grew 43% on a pro forma basis, or 84% on an as reported basis. Recall we acquired MiR in April of 2018. IA in total had a non-GAAP operating profit of 10% for the full year rate that we're modeling for 2020 as well. Shifting to our mid-term earnings model. Factoring in both recent history and our latest outlook, we've updated the high end of our $3.50 to $4 earnings target to $4.25 of non-GAAP EPS in 2022. We have growing confidence in the Semi Test end market drivers such as broader complexity for performance 5G subsets and millimeter wave driving capacity needs and infrastructure, phones and IoT devices. We also expect a continuation of the growing performance trends and memory devices. This along with some specific mobility and memory share gains and device unit growth, give us confidence to raise the Semi Test revenue growth rates from 3% to 5%; to 4% to 8% from our baseline 2019 revenue. At the same time to reflect near-term industry conditions IA's model growth rate has been reduced to a range of 20% to 35% off of our 2019 baseline revenue as Mark noted. We expect above 20% growth in 2020. In 2019, we experienced a significant slowdown in sales growth tied to macro conditions noted earlier. However, our long-term outlook remains positive. And we'll continue to invest in scaling the business. Specifically increasing our distributor capacity, sharpening our focus on marketing efforts for lead generation and closure, investing to expand our reach to major accounts, and continuing to invest in software solutions needed to scale our portfolio. The net result of these updated growth assumptions as a greater revenue contribution in 2022 from our test portfolio versus the prior model. Our gross margin target has increased roughly 1%, which drops down to operating profit, increasing that to 26% to 28% at the top end of our EPS rate, and increasing the top end of our EPS range to $4.25. Now to our outlook for Q1. Sales were expected to be between $670 million and $710 million. Non-GAAP EPS range of $0.86 to $0.96 on 174 million diluted shares. The first quarter guidance excludes the amortization of acquired intangibles, and non-cash imputed interest on the convertible debt. First quarter gross margins are estimated to be between 57% and 58%, down slightly from the fourth quarter due to mix. The first quarter OpEx running at 30% and 31% of first quarter sales is up about $6 million from the fourth quarter due to further IA distribution, and product development investments, including the addition of AutoGuide, along with incremental test investments I'll discuss shortly. The non-GAAP operating profit at the midpoint of the first quarter guidance is 27%. Now turning to some color around the full year outlook to help your model. As Mark noted, we expect strong first half similar to 2016 and 2017, when the first half revenues were 55% and 54% of the full year sales respectively. Key drivers of the first half revenue include handset test demand, system level testers being sold to enable key product ramp and our storage test second, and early ramping of LPDDR5 DRAM memory test capacity. Unlike 2016 and '17, based on our very early estimates, we expect roughly similar sales levels in Q2 as in Q1. Regarding our OpEx plans for 2020. We expect our OpEx to grow 10% to 12% from 2019 to $758 million. This is driven by investments across the business. In IA we will continue to invest to reinforce a competitive position across the sector as noted earlier. At our test portfolio we plan to increase our spending in engineering, sales and marketing primarily in Semi Test. The engineering efforts will include memory and SOC investments to maintain our leadership position, as well as invest in areas of the market that we believe there's opportunity for us to grow. Increased sales and marketing investments are driven by share gains, which require effort to convert and ramp customers on Teradyne's products and then provide ongoing support. Beyond 2020, we model test OpEx to have flat to GDP growth. Capital expenditures in 2012. We will increase above our normal run rate. In 2019, our CapEx was $145 million used primarily for customer demonstration equipment, operations and engineering. In 2020, we've earmarked an incremental $40 million or so for real estate investments in locations where we plan to grow significantly over the next several years. We are buying land and developing it to eliminate lease costs and enable more cost efficient spend profile over the long term. The projects will take two years to complete with the majority of the spending this year. Our GAAP and non-GAAP tax rate for 2020 is estimated at 16%. Shifting to capital allocation. We will continue to balance strong cash position to support our operating investments and potential M&A with direct shareholder returns through dividends and share repurchases. Recall we have a $460 million base value convertible bond that matures in 2023. Regarding direct returns, we will be increasing our dividend by 11% to $0.10 per quarter, which reflects our confidence in our operating level and growing markets we serve. With regards to share repurchases, we cancel the unused portion of the prior program and replace it with a $1 billion share repurchase program. We plan a minimum of $250 million of share repurchase in 2020. The program does not have a fixed end date and as in the past, there's a program programmatic and opportunistic component. Recall in 2018 and 2019, we spent approximately $1.3 billion in share buybacks, driven by 2017 tax reform, which enabled offshore cash to be repatriated efficiently. Our 2020 target represents our getting back to a more normal level on share repurchases. In summary, we closed out 2019 very strong and enter 2020 with good momentum powered by our strong test portfolio. Our updated capital allocation plan and earnings model reflects our confidence in test and industrial automation, while acknowledging the short term impacts of the global slowdown in industrial spending. We will continue to invest in R&D distribution and internal capabilities to improve our competitive position and drive profitable growth across the business. While we can't predict what lies ahead, for the full year, we have the products, the team, and a proven flexible business model that can efficiently scale demand during a fluctuating time period, and the strategy to thrive in the New Year. With that, I'll turn things back to Andy.